SHC-α5β1 integrin interactions regulate breast cancer cell adhesion and motility

Experimental Cell Research

Volumn 252, Issue 2, 1999, Pages 439-448

  Mauro, Loredana ^a,b   Sisci, Diego ^a,b   Bartucci, Monica ^a,b   Salerno, Michele ^a,b   Kim, Jerry ^a   Tam, Timothy ^a   Guvakova, Marina A ^a   Ando, Sebastiano ^b   Surmacz, Eva ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Breast cancer; Fibronectin; Motility; SHC; 5 1 integrin

Indexed keywords

INTEGRIN; FIBRONECTIN; FIBRONECTIN RECEPTOR; PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SRC HOMOLOGY 2 DOMAIN CONTAINING, TRANSFORMING PROTEIN 1; SRC HOMOLOGY 2 DOMAIN-CONTAINING, TRANSFORMING PROTEIN 1; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ARTICLE; BREAST CANCER; CELL ADHESION; CELL MOTILITY; CELL STRAIN MCF 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; BREAST TUMOR; CELL CULTURE; CELL MOTION; FEMALE; METABOLISM; PATHOLOGY; SRC HOMOLOGY DOMAIN;

MINK CELL FOCUS-FORMING VIRUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADAPTOR PROTEINS, VESICULAR TRANSPORT; BREAST NEOPLASMS; CELL ADHESION; CELL MOVEMENT; FEMALE; FIBRONECTINS; HUMANS; PROTEINS; RECEPTORS, FIBRONECTIN; SRC HOMOLOGY DOMAINS; TUMOR CELLS, CULTURED;

EID: 0033216537     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4639     Document Type: Article

References (38)

1. Pelicci G., Lafrancone L., Grignani F., McGlade J., Cavallo F., Forni G., Nicoletti I., Grignani F., Pawson T., Pelicci P. G. A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. Cell. 70:1992;93-104.
2. Pelicci G., Lafrancone L., Salcini A. E., Romano A., Mele S., Borrello M. G., Segatto O., Di Fiore P. P., Pelicci P. G. Constitutive phosphorylation of Shc proteins in human tumors. Oncogene. 11:1995a;899-907.
3. Lafrancone L., Pelicci G., Brizzi M. F., Aronica M. G., Casciari C., Giuli S., Pegoraro L., Pawson T., Pelicci P. G. Overexpression of Shc proteins potentiates the proliferative response to the granulocyte-macrophage colony-stimulating factor and recruitment of Grb2/SoS and Grb2/p140 complexes to the beta receptor subunit. Oncogene. 10:1995;907-917.
4. Rozakis-Adcock M., McGlade J., Mbamalu G., Pelicci G., Daly R., Li W., Batzer A., Thomas S., Brugge J., Pelicci P. G. Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature. 360:1992;689-692.
5. Pelicci G., Giordano S., Zhen Z., Salcini A. E., Lafrancone L., Bardeli A., Panayotou G., Waterfield M. D., Ponzetto C., Pelicci P. G., Comoglio P. M. The motogenic and mitogenic responses to HGF are amplified by the Shc adaptor protein. Oncogene. 10:1995b;1631-1638.
6. Salcini A. E., McGlade J., Pelicci G., Nicoletti I., Pawson T., Pelicci P. G. Formation of Shc-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of Shc proteins. Oncogene. 9:1994;2827-2836.
7. Migliaccio E., Mele S., Salcini A. E., Pelicci G., Lai K. M., Supreti-Furga G., Pawson T., Di Fiore P. P., Lafrancone L., Pelicci P. G. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signaling pathway. EMBO J. 16:1997;706-716.
8. Okada S., Kao A. W., Ceresa B. P., Blaikie P., Margolis B., Pessin J. E. The 66-kDa Shc isoform is a negative regulator of the epidermal growth factor-stimulated mitogen-activated protein kinase pathway. J. Biol. Chem. 272:1997;28042-28049.
9. Biscardi J. S., Belsches A. P., Pearsons S. J. Characterization of human epidermal growth factor receptor and c-Src interactions in human breast tumor cells. Mol. Carcinogen. 21:1998;261-272.
10. Stevenson L. E., Frackelton A. R. Constitutively tyrosine phosphorylated p52shc in breast cancer cells-correlation with ERB2 and p66shc expression. Breast Cancer Res. Treatm. 49:1998;119-128.
11. Matsuda M., Ota S., Tanimura R., Nakamura H., Matuoka K., Takenawa T., Nagashima K., Kurata T. Interactions between the amino-terminal SH3 domain of CRK and its natural target proteins. J. Biol. Chem. 271:1996;14468-14472.
12. Stein D., Wu J., Fuqua S. A., Roonprapunt C., Yajnik V., D'Eustachio P., Moskow J. J., Buchberg A. M., Osborne K., Margolis B. The SH2 domain protein GRB-7 is co-amplified, overexpressed and in a tight complex with HER2 in breast cancer. EMBO J. 13:1994;1331-1340.
13. Liu L., Damen J. E., Cutler R. L., Krystal G. Multiple cytokines stimulate the binding of a common 145-kilodalton protein to Shc at the Grb2 recognition site of Shc. Mol. Cell. Biol. 14:1994;6926-6935.
14. Kavanaugh W. M., Williams L. T. An alternative to SH2 domains for binding tyrosine-phosphorylated proteins. Science. 266:1994;1862-1865.
15. Habib T., Herrera R., Decker S. J. Activators of protein kinase C stimulate association of Shc and the PEST tyrosine phosphatase. J. Biol. Chem. 269:1994;25243-25246.
16. Nolan M., Jankowska L., Prisko M., Xu S., Guvakova M., Surmacz E. Differential roles of IRS-1 and SHC signaling pathways in breast cancer cells. Int. J. Cancer. 72:1997;828-834.
17. Sachs M., Weidner K. M., Brinkmann V., Walther I., Obermeier A., Ullrich A., Birchmeier W. Motogenic and morphogenic activity of epithelial receptor tyrosine kinases. J. Cell Biol. 133:1996;1095-1107.
18. Wary K. K., Mainiero F., Isakoff S. J., Marcantonio E. E., Giancotti F. G. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression. Cell. 87:1996;733-743.
19. Wary K. K., Mariotti A., Zurzolo C., Giancotti F. G. A requirement for caveolin-1 and associated kinase Fyn in integrin signaling and anchorage-dependent cell growth. Cell. 94:1998;625-634.
20. Schlaepfer D. D., Hunter T. Focal adhesion kinase overexpression enhances ras-dependent integrin signaling to ERK2/mitogen-activated kinase through interactions with and activation of c-Src. J. Biol. Chem. 272:1997;13189-13195.
21. Schlaepfer D. D., Jones K. C., Hunter T. Multiple Grb-2-mediated integrin-stimulated signaling pathways to ERK2/mitogen-activated protein kinase: Summation of both c-Src and focal adhesion kinase-initiated tyrosine phosphorylation events. Mol. Cell. Biol. 18:1998;2571-2585.
22. Pozzi A., Wary K. K., Giancotti F. G., Gardener H. A. Integrin alpha 1 beta1 mediates a unique collagen-dependent proliferation pathway in vivo. J. Cell Biol. 142:1998;587-594.
23. Cary L. A., Han D. C., Polte T. R., Hanks S. K., Guan J-L. Identification of p130Cas as a mediator of focal adhesion kinase-promoted cell migration. J. Cell Biol. 140:1998;211-221.
24. Giorgetti S., Pelicci P. G., Pelicci G., Van Oberghen E. Involvement of Src-homology/collagen (SHC) proteins in signaling through the insulin receptor and the insulin-like growth factor-I-receptor. Eur. J. Biochem. 223:1994;195-202.
25. Migliaccio A., Di Domenico M., Castoria G., de Falco A., Bontempo P., Nola E., Auricchio F. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J. 15:1996;1292-1300.
26. Doerr M. E., Jones J. I. The roles of integrins and extracellular matrix proteins in the IGF-IR-stimulated chemotaxis of human breast cancer cells. J. Biol. Chem. 271:1996;2443-2447.
27. Akiyama S. K., Olden K., Yamada K. M. Fibronectin and integrins in invasion and metastasis. Cancer Metast. Rev. 14:1995;173-189.
28. Plantefaber L. C., Hynes R. O. Changes in integrin receptors on oncogenically transformed cells. Cell. 56:1989;281-290.
29. Giancotti F. G., Ruoslahti E. Elevated levels of the alpha 5 beta 1 fibronectin receptor supress the transformed phenotype of Chinese hamster ovary cells. Cell. 60:1990;849-859.
30. Wang D., Sun L., Zborowska E., Willson J. K. V., Gong J., Verraraghavan J., Brattain M. G. Control of type II transforming growth factor beta receptor expression by integrin ligation. J. Biol. Chem. 247:1999;12840-12847.
31. Murthy M. S., Reid S. E. Jr., Yang X. F., Scanlon E. P. The potential role of integrin receptor subunits in the formation of local recurrence and distant metastasis by mouse breast cancer cells. J. Surg. Oncol. 63:1996;77-86.
32. Surmacz E., Burgaud J-L. Overexpression of IRS-1 in the human breast cancer cell line MCF-7 induces loss of estrogen requirements for growth and transformation. Clin. Cancer Res. 1:1995;1429-1436.
33. Guvakova M. A., Surmacz E. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival and promote cell-cell adhesion in human breast cancer cells. Exp. Cell Res. 231:1997;149-162.
34. Mainiero F., Pepe A., Yeon M., Ren Y., Giancotti F. G. The intracellular functions of alpha6beta4 integrin are regulated by EGF. The intracellular functions of alpha6 beta4 integrin are regulated by EGF. J. Cell Biol. 134:1996;241-253.
35. Clark E. A., Brugge J. S. Integrins and signal transduction pathways: The road taken. Science. 268:1995;233-239.
36. Sommers C. L., Papagerge A., Wilding G., Gelmann E. P. Growth properties and tumorigenesis of MCF-7 cells transfected with isogenic mutants of rasH. Cancer Res. 50:1990;67-71.
37. Reiss K., Valentinis B., Tu X., Xu S., Baserga R. Molecular markers of IGF-I-mediated mitogenesis. Exp. Cell Res. 242:1998;361-372.
38. Jackson J. G., White M. F., Yee D. Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-I, insulin, and interleukin-4 in estrogen receptor positive human breast cancer cells. J. Biol. Chem. 273:1998;9994-10003.